CN103923014A - Preparation method of cyclocreatine - Google Patents

Preparation method of cyclocreatine Download PDF

Info

Publication number
CN103923014A
CN103923014A CN201410185623.0A CN201410185623A CN103923014A CN 103923014 A CN103923014 A CN 103923014A CN 201410185623 A CN201410185623 A CN 201410185623A CN 103923014 A CN103923014 A CN 103923014A
Authority
CN
China
Prior art keywords
ethylenediamine
preparation
quadrol
sodium
acetonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410185623.0A
Other languages
Chinese (zh)
Inventor
马杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NINGXIA BAOMA PHARMACEUTICAL Co Ltd
Original Assignee
NINGXIA BAOMA PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NINGXIA BAOMA PHARMACEUTICAL Co Ltd filed Critical NINGXIA BAOMA PHARMACEUTICAL Co Ltd
Priority to CN201410185623.0A priority Critical patent/CN103923014A/en
Publication of CN103923014A publication Critical patent/CN103923014A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/46Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms attached to said nitrogen atoms

Abstract

The invention relates to a preparation method of cyclocreatine. The preparation method comprises the following steps: condensing ethylenediamine and hydroxyl acetonitrile serving as raw materials at 0-20 DEG C to obtain ethylenediamine acetonitrile; then, carrying out catalytic hydrolysis on ethylenediamine acetonitrile and sodium hydroxide at 60-100 DEG C to obtain ethylenediamine sodium acetate; and then, adding and cyclizing ethylenediamine sodium acetate in the environment of a methanol solution through nitrile brominate to obtain cyclocreatine. The preparation method provided by the invention is short in synthetic line, and byproducts can be recycled, so that no solid and gas residues are generated. Ammonia gas produced in the process is absorbed by water to be sold as ammonia water. Solid sodium bromide is obtained in a way of sodium bromide formed by a product mother liquid through decompressed concentration and can be sold as an inorganic chemical material.

Description

Circular muscle acid preparation method
technical field:
The present invention relates to a kind of circular muscle acid preparation method.
background technology:
Circular muscle acidifying formal name used at school is called 2-imino--1-imidazolidine acetic acid, and structural formula is:
The current bibliographical information of application of circular muscle acid is few, and it is the nonessential amino acid of human body for just current contents known, is the amino acid that contains imidazolyl heterocycle, and it is known as sports nutrition product, and meanwhile, it has antitumous effect report.Circular muscle acid is expensive, not yet finds at present manufacturer, and the bibliographical information of its synthetic method and synthesis condition has no open.
summary of the invention:
Given this, be necessary to find a kind of circular muscle acid preparation method.
A kind of circular muscle acid preparation method, obtains quadrol base acetonitrile taking quadrol and hydroxyacetonitrile as raw material reacts condensation at 0 ~ 20 DEG C:
,(1)
Then quadrol base acetonitrile is obtained to quadrol guanidine-acetic acid sodium with sodium hydroxide catalytic hydrolysis at 60 ~ 100 DEG C:
, (2)
Again quadrol guanidine-acetic acid sodium is obtained to circular muscle acid through bromination nitrile addition cyclization under methanol solution environment:
, (3)
Preferably, the temperature of reaction of formula (1) is 20 DEG C, and the temperature of reaction of formula (2) is 100 DEG C.
Synthesis path of the present invention is short, and the equal recoverable of byproduct does not have solid, gas residue dirt, the ammonia water producing in technique absorbs to be sold as ammoniacal liquor, the Sodium Bromide that finished mother liquid forms, obtains solid brominated sodium by concentrating under reduced pressure, can be used as Inorganic Chemicals and sells.This technique has all played active effect from environmental protection or cost.
embodiment:
A kind of circular muscle acid preparation method, obtains quadrol base acetonitrile taking quadrol and hydroxyacetonitrile as raw material reacts condensation at 0 ~ 20 DEG C:
,(1)
Then quadrol base acetonitrile is obtained to quadrol guanidine-acetic acid sodium with sodium hydroxide catalytic hydrolysis at 60 ~ 100 DEG C:
, (2)
Again quadrol guanidine-acetic acid sodium is obtained to circular muscle acid through bromination nitrile addition cyclization under methanol solution environment:
, (3)
In the present embodiment, the temperature of reaction of formula (1) is 20 DEG C, and the temperature of reaction of formula (2) is 100 DEG C.

Claims (2)

1. a circular muscle acid preparation method, is characterized in that: obtain quadrol base acetonitrile taking quadrol and hydroxyacetonitrile as raw material reacts condensation at 0 ~ 20 DEG C:
,(1)
Then quadrol base acetonitrile is obtained to quadrol guanidine-acetic acid sodium with sodium hydroxide catalytic hydrolysis at 60 ~ 100 DEG C:
, (2)
Again quadrol guanidine-acetic acid sodium is obtained to circular muscle acid through bromination nitrile addition cyclization under methanol solution environment:
, (3)。
2. circular muscle acid preparation method as claimed in claim 1, is characterized in that: the temperature of reaction of formula (1) is 20 DEG C, and the temperature of reaction of formula (2) is 100 DEG C.
CN201410185623.0A 2014-05-05 2014-05-05 Preparation method of cyclocreatine Pending CN103923014A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410185623.0A CN103923014A (en) 2014-05-05 2014-05-05 Preparation method of cyclocreatine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410185623.0A CN103923014A (en) 2014-05-05 2014-05-05 Preparation method of cyclocreatine

Publications (1)

Publication Number Publication Date
CN103923014A true CN103923014A (en) 2014-07-16

Family

ID=51141437

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410185623.0A Pending CN103923014A (en) 2014-05-05 2014-05-05 Preparation method of cyclocreatine

Country Status (1)

Country Link
CN (1) CN103923014A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016036699A1 (en) * 2014-09-03 2016-03-10 Lumos Pharma, Inc. Synthesis of cyclocreatine and analogs thereof
JP2018513122A (en) * 2015-03-11 2018-05-24 ルモス ファーマ, インコーポレイテッド Synthesis of cyclocreatine and its analogues

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1439005A (en) * 2000-02-15 2003-08-27 苏根公司 Pyrrole substituted 2-indolinone protein kinase inhibitors
CN1541098A (en) * 2001-08-15 2004-10-27 �ո��� Combination therapy for treatment of cancer
WO2006073923A2 (en) * 2004-12-30 2006-07-13 Nour Heart, Inc. Phosphagen synthesis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1439005A (en) * 2000-02-15 2003-08-27 苏根公司 Pyrrole substituted 2-indolinone protein kinase inhibitors
CN1541098A (en) * 2001-08-15 2004-10-27 �ո��� Combination therapy for treatment of cancer
WO2006073923A2 (en) * 2004-12-30 2006-07-13 Nour Heart, Inc. Phosphagen synthesis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROWLEY G. L.等: "On the Specificity of Creatine Kinase. New Glycocyamines and Glycocyamine Analogs Related to Creatine", 《J. AM. CHEM. SOC.》 *
姚方等: "肌氨酸钠的合成研究", 《科技进展》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016036699A1 (en) * 2014-09-03 2016-03-10 Lumos Pharma, Inc. Synthesis of cyclocreatine and analogs thereof
CN107001280A (en) * 2014-09-03 2017-08-01 卢莫斯制药公司 The synthesis of circular muscle acid and the like
AU2015312159B2 (en) * 2014-09-03 2019-03-07 Lumos Pharma, Inc. Synthesis of cyclocreatine and analogs thereof
US10493062B2 (en) 2014-09-03 2019-12-03 Lumos Pharma, Inc. Synthesis of cyclocreatine and analogs thereof
JP2018513122A (en) * 2015-03-11 2018-05-24 ルモス ファーマ, インコーポレイテッド Synthesis of cyclocreatine and its analogues
US10081605B2 (en) 2015-03-11 2018-09-25 Lumos Pharma, Inc. Synthesis of cyclocreatine and analogs thereof
US10377721B2 (en) 2015-03-11 2019-08-13 Lumos Pharma, Inc. Synthesis of cyclocreatine and analogs thereof

Similar Documents

Publication Publication Date Title
TR201904615T4 (en) Process for producing 1,4-butanediol.
JP2012515131A5 (en)
CN105601542B (en) A kind of method that nitration mixture crystallizes N carbamylglutamic acids
CN103923014A (en) Preparation method of cyclocreatine
WO2015079239A3 (en) Waste treatment process comprising treating waste stream with base at elevated temperature
WO2019013954A8 (en) Process for producing long chain amino acids and dibasic acids
CN103382166A (en) Method for preparing 2, 6-dichlorobenzonitrile
JP2013503913A5 (en)
CN101823974A (en) Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine
CN103274954B (en) A kind of glycine production technique
BR112013005421A2 (en) "process for producing polyamides, and use of polyamides".
Ortial et al. Synthesis of cis-5-trifluoromethylproline from L-glutamic acid
CN101914070B (en) Synthesis method of henazine-2,3-diamine hydrochloride
JP2015182974A (en) Method of producing triethylenetetramine
CN104592093A (en) Synthetic process of rubber scorch retarder CPT
CN103319376B (en) The preparation method of creatine hydrochloride
CN103408418A (en) Preparation and purification method of solid malonic acid
WO2014133291A9 (en) Method for preparing (2rs)-amino-(3s)-hydroxy-butyric acid or derivative thereof
CN107383076A (en) A kind of synthetic method of the chlorophenylboronic acid pinacol ester of 3 amino 4
CN107868013A (en) The production method of industrial grade glycine
CN206502762U (en) Prepare the process system of carnosine
US9902697B2 (en) Method for producing 2-amino-6-methylnicotinic acid
CN103772379B (en) A kind of preparation method of trospium chloride key intermediate
Yamamoto et al. Construction of Peptide Linkages by Using Sulfuryl Fluoride
CN102020582A (en) Method for synthesizing N-hydroxymethyl acrylamide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140716